Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  75,150 results for ""DENSITY""

Your Filters

Publisher : wiley-blackwell Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density.

  • Authors : Sayed SA; Clinical Pharmacy Department, Faculty of Pharmacy, Nahda University, Beni-suef, Egypt.; El Wakeel LM

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Kidney Transplantation*/Kidney Transplantation*/Kidney Transplantation*/adverse effects; Humans

  • Source: Pharmacotherapy [Pharmacotherapy] 2023 Sep; Vol. 43 (9), pp. 904-912. Date of Electronic Publication: 2023 Jun 22.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

The LRP5 high-bone-mass mutation causes alveolar bone accrual with minor craniofacial alteration.

  • Authors : Turkkahraman H; Department of Orthodontics and Oral Facial Genetics, Indiana University School of Dentistry, Indianapolis, Indiana, USA.; Flanagan S

Subjects: Low Density Lipoprotein Receptor-Related Protein-5*/Low Density Lipoprotein Receptor-Related Protein-5*/Low Density Lipoprotein Receptor-Related Protein-5*/genetics ; Low Density Lipoprotein Receptor-Related Protein-5*/Low Density Lipoprotein Receptor-Related Protein-5*/Low Density Lipoprotein Receptor-Related Protein-5*/metabolism ; Bone and Bones*/Bone and Bones*/Bone and Bones*/metabolism

  • Source: Journal of periodontal research [J Periodontal Res] 2023 Aug; Vol. 58 (4), pp. 723-732. Date of Electronic Publication: 2023 May 02.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0055107 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Cerebral palsy and bisphosphonates - and what can be learned from other types of secondary osteoporosis in children: A scoping review.

Subjects: Bone Density Conservation Agents* ; Cerebral Palsy*/Cerebral Palsy*/Cerebral Palsy*/complications ; Fractures, Bone*

  • Source: Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2023 Apr; Vol. 112 (4), pp. 617-629. Date of Electronic Publication: 2023 Feb 01.Publisher: Wiley-Blackwell Country of Publication: Norway NLM ID: 9205968 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Bisphosphonate treatment for skeletal complications in paediatric cancer-Experience from a single tertiary centre.

  • Authors : Utriainen P; Department of Pediatric Hematology and Oncology and Stem Cell Transplantation, Children's Hospital and Pediatric Research Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Research Program Unit for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Subjects: Diphosphonates*/Diphosphonates*/Diphosphonates*/therapeutic use ; Diphosphonates*/Diphosphonates*/Diphosphonates*/adverse effects ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2024 Jun; Vol. 113 (6), pp. 1446-1452. Date of Electronic Publication: 2024 Feb 08.Publisher: Wiley-Blackwell Country of Publication: Norway NLM ID: 9205968 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of oral zoledronate administration on bone turnover in older women.

  • Authors : Reid IR; Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.; Auckland District Health Board, Auckland, New Zealand.

Subjects: Bone Resorption* ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Mar; Vol. 89 (3), pp. 1099-1104. Date of Electronic Publication: 2022 Oct 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Population assessment of the Endangered Kashmir Gray Langur (Semnopithecus ajax, Pocock 1928) using the double-observer method.

  • Authors : Hameed S; Department of Environmental Sciences & Centre of Research for Development, University of Kashmir, Srinagar, India.; Bashir T

Subjects: Endangered Species* ; Population Density*; Animals

  • Source: American journal of primatology [Am J Primatol] 2024 Jun; Vol. 86 (6), pp. e23618. Date of Electronic Publication: 2024 Mar 14.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8108949 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Risk of fractures and use of bisphosphonates in adult patients with immune thrombocytopenia-A nationwide population-based study.

  • Authors : Mannering N; Department of Haematology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Subjects: Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/drug therapy ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/epidemiology ; Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/Purpura, Thrombocytopenic, Idiopathic*/chemically induced

  • Source: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1464-1475. Date of Electronic Publication: 2024 Feb 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.

  • Authors : Pedersen MA; Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Bendamustine Hydrochloride*/Bendamustine Hydrochloride*/Bendamustine Hydrochloride*/adverse effects ; Bone Density*

  • Source: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1271-1278. Date of Electronic Publication: 2023 Nov 13.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of COVID-19 pandemic on lifestyle and bone mineral density in young adults.

  • Authors : Falbová D; Department of Anthropology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.; Kovalčíková V

Subjects: Bone Density* ; COVID-19*/COVID-19*/COVID-19*/epidemiology; Humans

  • Source: American journal of human biology : the official journal of the Human Biology Council [Am J Hum Biol] 2024 Apr; Vol. 36 (4), pp. e24009. Date of Electronic Publication: 2023 Nov Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8915029 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of growth, puberty, osteoporosis, and the response to long-term bisphosphonate therapy in four patients with osteoporosis-pseudoglioma syndrome.

  • Authors : Karakilic-Ozturan E; Istanbul Faculty of Medicine, Department of Pediatrics, Pediatric Endocrinology Unit, Istanbul University, Istanbul, Turkey.; Altunoglu U

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/pharmacology ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy Osteoporosis-pseudoglioma syndrome

  • Source: American journal of medical genetics. Part A [Am J Med Genet A] 2022 Jul; Vol. 188 (7), pp. 2061-2070. Date of Electronic Publication: 2022 Apr 08.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  75,150 results for ""DENSITY""